AFL 애플랙 · AFLAC Incorporated

애널리스트 전망 상향 우세, 매출 +14% 성장. 다만 90일 내부자 매도 $9,080만. 11/4 실적 발표 예정.

종가$120.15
시가총액$601억
업종금융
다음 실적 발표2026-11-04
PER12.4배
매출 성장(최근 4분기)+14%
애널리스트 순상향률+27%
목표가 상승여력-2.3%
공매도 거래 비중41%
1년 수익률+13%

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental de

2026-10-21 기준 · 출처: SEC EDGAR, FINRA, yfinance · 정보 제공용이며 투자 권유가 아닙니다

같은 업종 종목